{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-029591","form_type":"8-K","ticker":"RCUS","cik":"0001724521","company_name":"Arcus Biosciences, Inc.","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.623698+00:00","generated_at":"2026-05-26T12:17:54.342913+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arcus Biosciences raises ~$141.6M in public offering of 13.6M shares at $11.00/share","bullets":["Offered 13,636,364 shares at $11.00/share, yielding ~$141.6M net proceeds after expenses.","Proceeds to fund R&D activities, including clinical development of casdatifan, manufacturing, and general corporate purposes.","Offering closed on Feb 19, 2025; underwritten by Goldman Sachs and Leerink Partners.","Shares sold under existing shelf registration statement (Form S-3) filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-029591","json":"https://secwatch.observer/filing/0001193125-25-029591.json","markdown":"https://secwatch.observer/filing/0001193125-25-029591.md","text":"https://secwatch.observer/filing/0001193125-25-029591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1724521/000119312525029591/0001193125-25-029591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1724521/000119312525029591/d932072d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:17:54.342913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}